Abstract
Introduction: The aim of the study was to evaluate the diabetic activity of diarylsulfonylurea-chalcone hybrids on streptozotocin (STZ)-induced diabetic male albino rats. Materials and Methods: Diabetic activity of diarylsulfonylurea-chalcone hybrids at a dose of 10, 30, and 50 mg/kg body weight was evaluated. Adult male Swiss albino rats of six numbers in each group were undertaken for study and evaluated. Results: The results of in vivo hypoglycemic and antihyperglycemic activity of the synthesized diarylsulfonylurea-chalcone hybrid molecules (II.1-28) showed that all the compounds were found to possess moderate to potential ability to reduce blood glucose levels in normoglycemic and STZ-induced type 2 diabetic rats. Conclusions: The diarylsulfonylurea-chalcone hybrids have potent diabetic activity in the male albino rat.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
